Ischemic biomarkers and their use to predict adverse neurological events from sugery

Details for Australian Patent Application No. 2006208239 (hide)

Owner CIS Biotech, Inc.

Inventors Dambinova, Svetlana A.

Agent Griffith Hack

Pub. Number AU-A-2006208239

PCT Pub. Number WO2006/081188

Priority 60/646,762 25.01.05 US

Filing date 24 January 2006

Wipo publication date 3 August 2006

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/537 (2006.01) Investigating or analysing materials by specific methods not covered by groups

G01N 33/543 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with an insoluble carrier for immobilising immunochemicals

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/081188 Priority application(s): WO2006/081188

22 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006208241-Compositions and methods for treating cardiac conditions

2006208226-Humanized anti-amyloid antibody